{"disease":{"id":"sars-cov-2-infection-covid-19","name":"sars cov 2 infection covid 19"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT04915781","title":"Tobacco Use and COVID-19 Incidence in the Finnish General Population","phase":"","overall_status":"COMPLETED","enrollment_count":60872,"lead_sponsor_name":"Finnish Institute for Health and Welfare","has_results":false},{"nct_id":"NCT04368728","title":"Study to Describe the Safety, Tolerability, Immunogenicity, and Efficacy of RNA Vaccine Candidates Against COVID-19 in Healthy Individuals","phase":"PHASE2, PHASE3","overall_status":"COMPLETED","enrollment_count":46969,"lead_sponsor_name":"BioNTech SE","has_results":true},{"nct_id":"NCT04955626","title":"To Evaluate the Safety, Tolerability, Efficacy and Immunogenicity of BNT162b2 Boosting Strategies Against COVID-19 in Participants ≥12 Years of Age.","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":16372,"lead_sponsor_name":"BioNTech SE","has_results":true},{"nct_id":"NCT04583995","title":"A Study Looking at the Effectiveness, Immune Response, and Safety of a COVID-19 Vaccine in Adults in the United Kingdom","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":15185,"lead_sponsor_name":"Novavax","has_results":false},{"nct_id":"NCT05168813","title":"Efficacy Study of COVID-19 mRNA Vaccine in Regions With SARS-CoV-2 Variants of Concern","phase":"PHASE2, PHASE3","overall_status":"COMPLETED","enrollment_count":14237,"lead_sponsor_name":"COVID-19 Prevention Network","has_results":true},{"nct_id":"NCT04922788","title":"Study to Evaluate the Safety, Immunogenicity, and Efficacy of Nanocovax Vaccine Against COVID-19","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":13006,"lead_sponsor_name":"Nanogen Pharmaceutical Biotechnology Joint Stock Company","has_results":false},{"nct_id":"NCT04816643","title":"A Phase 1/2/3 Study to Evaluate the Safety, Tolerability, and Immunogenicity of an RNA Vaccine Candidate Against COVID-19 in Healthy Children","phase":"PHASE2, PHASE3","overall_status":"COMPLETED","enrollment_count":11837,"lead_sponsor_name":"BioNTech SE","has_results":false},{"nct_id":"NCT06170320","title":"STREngthening COronavirus Disease 2019 (COVID-19) Surveillance in Africa","phase":"","overall_status":"COMPLETED","enrollment_count":7000,"lead_sponsor_name":"Institut de Recherche pour le Developpement","has_results":false},{"nct_id":"NCT04578509","title":"Evaluation of a Screening Program for SARS-CoV-2 Infection in the General Population Based on the Use of New Detection Approaches or for Diagnostic Orientation on Saliva","phase":"","overall_status":"COMPLETED","enrollment_count":5197,"lead_sponsor_name":"Assistance Publique - Hôpitaux de Paris","has_results":false},{"nct_id":"NCT04533399","title":"A Study Looking at the Effectiveness and Safety of a COVID-19 Vaccine in South African Adults","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":4422,"lead_sponsor_name":"Novavax","has_results":false},{"nct_id":"NCT04913116","title":"Generic Testing of Antigen Tests for COVID-19 in Denmark","phase":"","overall_status":"COMPLETED","enrollment_count":4000,"lead_sponsor_name":"Hvidovre University Hospital","has_results":false},{"nct_id":"NCT04636203","title":"Burden of COVID-19 Infection in Populations With High or Low Risk of Infection","phase":"","overall_status":"COMPLETED","enrollment_count":4000,"lead_sponsor_name":"Neuromed IRCCS","has_results":false},{"nct_id":"NCT04354779","title":"Antibody Seroprevalence and Rate of Asymptomatic Infections With SARS-CoV-2 in Austrian Hospital Personnel.","phase":"","overall_status":"COMPLETED","enrollment_count":3301,"lead_sponsor_name":"AUVA","has_results":false},{"nct_id":"NCT05629962","title":"SUNRISE-3: Efficacy and Safety of Bemnifosbuvir in High-Risk Outpatients With COVID-19","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":2285,"lead_sponsor_name":"Atea Pharmaceuticals, Inc.","has_results":true},{"nct_id":"NCT04483960","title":"Australasian COVID-19 Trial (ASCOT) ADAptive Platform Trial","phase":"PHASE3","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":2200,"lead_sponsor_name":"University of Melbourne","has_results":false},{"nct_id":"NCT04613817","title":"Sero-prevalence COVID-19 Among Belgian Children","phase":"","overall_status":"COMPLETED","enrollment_count":2103,"lead_sponsor_name":"Sciensano","has_results":false},{"nct_id":"NCT05852873","title":"PAxlovid loNg cOvid-19 pRevention triAl With recruitMent In the Community in Norway","phase":"PHASE3","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":2000,"lead_sponsor_name":"Haukeland University Hospital","has_results":false},{"nct_id":"NCT05162508","title":"Impact of COVID-19 SARS-CoV-2 Variability in ICU Hospitalized Patients With Severe Disease","phase":"","overall_status":"UNKNOWN","enrollment_count":2000,"lead_sponsor_name":"Assistance Publique - Hôpitaux de Paris","has_results":false},{"nct_id":"NCT04713553","title":"A Phase 3 Study to Evaluate the Safety, Tolerability, and Immunogenicity of Multiple Production Lots and Dose Levels of BNT162b2 RNA-Based COVID-19 Vaccines Against COVID-19 in Healthy Participants","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":1574,"lead_sponsor_name":"BioNTech SE","has_results":true},{"nct_id":"NCT05472038","title":"A Study to Learn About New COVID-19 RNA Vaccine Candidates in COVID-19 Vaccine-Experienced Healthy Individuals","phase":"PHASE2, PHASE3","overall_status":"COMPLETED","enrollment_count":1453,"lead_sponsor_name":"BioNTech SE","has_results":true},{"nct_id":"NCT05004181","title":"Safety and Immunogenicity of RNA-based Vaccines Against SARS-CoV-2 Variants in Healthy Participants","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":1380,"lead_sponsor_name":"BioNTech SE","has_results":true},{"nct_id":"NCT04795414","title":"Safety and Immunogenicity of an Inactivated Vaccine Against COVID-19 in Medical Workers","phase":"","overall_status":"UNKNOWN","enrollment_count":1370,"lead_sponsor_name":"Ruijin Hospital","has_results":false},{"nct_id":"NCT05310084","title":"Safety and Immunogenicity of BNT162b2 Coadministered With SIIV in Adults 18 Through 64 Years of Age","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":1134,"lead_sponsor_name":"BioNTech SE","has_results":true},{"nct_id":"NCT05244343","title":"I VACCIN Hospitalization of COVID-19 Patients","phase":"","overall_status":"COMPLETED","enrollment_count":1096,"lead_sponsor_name":"Eshmoun Clinical Research Center","has_results":false},{"nct_id":"NCT05997290","title":"A Study to Learn About New COVD-19 RNA Vaccine Candidates for New Variants in Healthy Individuals","phase":"PHASE2, PHASE3","overall_status":"COMPLETED","enrollment_count":1051,"lead_sponsor_name":"BioNTech SE","has_results":false},{"nct_id":"NCT04898738","title":"Prospective COVID-19 Cohort Study, Dominican Republic","phase":"NA","overall_status":"COMPLETED","enrollment_count":1043,"lead_sponsor_name":"Brigham and Women's Hospital","has_results":false},{"nct_id":"NCT05069090","title":"Effect of COVID-19 Lockdown on Alcohol and Tobacco Use in Two Chilean Universities","phase":"","overall_status":"COMPLETED","enrollment_count":1038,"lead_sponsor_name":"Universidad de La Frontera","has_results":false},{"nct_id":"NCT05303168","title":"Prevalence and Impact of COVID-19 on Maternal and Infant Health in African Populations","phase":"","overall_status":"COMPLETED","enrollment_count":1000,"lead_sponsor_name":"Barcelona Institute for Global Health","has_results":false},{"nct_id":"NCT05279365","title":"PROSPECTIVE OPEN LABEL CLINICAL TRIAL TO ADMINISTER A BOOSTER DOSE OF PFIZER/BIONTECH OR MODERNA COVID-19 VACCINE IN HIGH-RISK INDIVIDUALS","phase":"PHASE2, PHASE3","overall_status":"UNKNOWN","enrollment_count":1000,"lead_sponsor_name":"DHR Health Institute for Research and Development","has_results":false},{"nct_id":"NCT06435403","title":"SARS-CoV-2 Specific Antibody Responses and Impact for COVID-19 Disease in Ethiopia","phase":"","overall_status":"RECRUITING","enrollment_count":1000,"lead_sponsor_name":"Michael Hoelscher","has_results":false},{"nct_id":"NCT04910269","title":"Outpatient Treatment With Anti-Coronavirus Immunoglobulin","phase":"PHASE3","overall_status":"RECRUITING","enrollment_count":820,"lead_sponsor_name":"University of Minnesota","has_results":false},{"nct_id":"NCT04754594","title":"To Evaluate the Safety, Tolerability, and Immunogenicity of BNT162b2 Against COVID-19 in Healthy Pregnant Women 18 Years of Age and Older","phase":"PHASE2, PHASE3","overall_status":"COMPLETED","enrollment_count":726,"lead_sponsor_name":"BioNTech SE","has_results":true},{"nct_id":"NCT06237049","title":"A Study to Learn About a Combined COVID-19 and Influenza Shot in Healthy Adults","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":644,"lead_sponsor_name":"Pfizer","has_results":true},{"nct_id":"NCT04816669","title":"A Study to Evaluate Safety, Tolerability, & Immunogenicity of Multiple Formulations of BNT162b2 Against COVID-19 in Healthy Adults","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":629,"lead_sponsor_name":"BioNTech SE","has_results":true},{"nct_id":"NCT06631287","title":"Randomized Double-Blind Placebo-Controlled Trial EValuating Baricitinib on PERSistent NEurologic and Cardiopulmonary Symptoms of Long COVID","phase":"PHASE3","overall_status":"RECRUITING","enrollment_count":550,"lead_sponsor_name":"Wes Ely","has_results":false},{"nct_id":"NCT04739020","title":"Respiratory Aerosols in Patients With COVID-19 and Healthy Controls","phase":"NA","overall_status":"UNKNOWN","enrollment_count":525,"lead_sponsor_name":"Johann Wolfgang Goethe University Hospital","has_results":false},{"nct_id":"NCT04964115","title":"Post Acute Sequelae of COVID-19","phase":"","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":500,"lead_sponsor_name":"Vanderbilt University Medical Center","has_results":false},{"nct_id":"NCT05256602","title":"Prevalence of Knowledge, Attitudes and Perception of Covid Vaccine in Iraq. A Cross Sectional Study","phase":"","overall_status":"UNKNOWN","enrollment_count":500,"lead_sponsor_name":"AlFayhaa General Hospital","has_results":false},{"nct_id":"NCT04500639","title":"Over-the-counter Medications & COVID-19","phase":"","overall_status":"COMPLETED","enrollment_count":461,"lead_sponsor_name":"University of Alberta","has_results":false},{"nct_id":"NCT05329051","title":"A Study to Evaluate the Immunogenicity and Safety of a Recombinant Protein COVID-19 Vaccine in Population Aged ≥18 Years","phase":"PHASE2","overall_status":"UNKNOWN","enrollment_count":400,"lead_sponsor_name":"Sinocelltech Ltd.","has_results":false},{"nct_id":"NCT05541861","title":"Safety and Effects of an Investigational COVID-19 Vaccine as Booster in Healthy People","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":383,"lead_sponsor_name":"BioNTech SE","has_results":true},{"nct_id":"NCT04916639","title":"Seawater Nasal Wash to Relieve COVID-19 Nasal Symptoms and Reduce SARS-CoV-2 Viral Load.","phase":"NA","overall_status":"COMPLETED","enrollment_count":370,"lead_sponsor_name":"Laboratoire de la Mer","has_results":false},{"nct_id":"NCT04747158","title":"COVID-19 Convalescent Plasma Therapy","phase":"PHASE2, PHASE3","overall_status":"COMPLETED","enrollment_count":350,"lead_sponsor_name":"Universidad Nacional de Asunción","has_results":false},{"nct_id":"NCT05667597","title":"Sars-COV-2 (COVID-19) Immunity in immunoCOmpromised Populations","phase":"NA","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":350,"lead_sponsor_name":"Maria Goossens","has_results":false},{"nct_id":"NCT05043623","title":"Diagnosis of Respiratory Viruses in Children With Rhinoswab Junior","phase":"NA","overall_status":"COMPLETED","enrollment_count":339,"lead_sponsor_name":"Murdoch Childrens Research Institute","has_results":false},{"nct_id":"NCT05584176","title":"COVID-19 MP Biomedicals SARS-CoV-2 Ag OTC: Clinical Evaluation","phase":"NA","overall_status":"COMPLETED","enrollment_count":332,"lead_sponsor_name":"MP Biomedicals, LLC","has_results":true},{"nct_id":"NCT04303299","title":"Fight COVID-19 Trial","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":320,"lead_sponsor_name":"Department of Medical Services Ministry of Public Health of Thailand","has_results":false},{"nct_id":"NCT04993560","title":"Safety and Efficacy of COVID-19 Prime-boost Vaccine in Bahrain","phase":"","overall_status":"COMPLETED","enrollment_count":305,"lead_sponsor_name":"Royal College of Surgeons in Ireland - Medical University of Bahrain","has_results":false},{"nct_id":"NCT05765396","title":"SARS-CoV-2/COVID-19 Study of Next Generation Non-Invasive Passive Detection Technologies","phase":"","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":300,"lead_sponsor_name":"The Geneva Foundation","has_results":false},{"nct_id":"NCT05055466","title":"COVID-19: Infectious Potential of SARS-CoV-2 Intestinal Shedding in Pediatric Patients (INPOSIS)","phase":"","overall_status":"COMPLETED","enrollment_count":283,"lead_sponsor_name":"St. Anna Kinderkrebsforschung","has_results":false}],"total":50},"guidelines":[],"source":"Drug Landscape verified database"}